(MENAFN- PR Newswire) DUBLIN, Nov. 25, 2022 /PRNewswire/ --
The 'u.s. gene editing market - industry outlook & forecast 2022-2027' report has been added to
ResearchAndMarkets.com's offering.
The U.S. gene editing market is expected to grow at a CAGR of 21.13% during 2022-2027. MARKET INSIGHTS Growth in the gene editing market is fueled by increasing demand for synthetic genes in the U.S. Genomics can be used to identify genetic abnormalities in humans, drug discovery, agriculture, veterinary medicine, and forensics. Gene editing requires tools and techniques that make unique changes to the DNA sequence of an organism's genes, fundamentally altering the genetic blueprint. Unlike genetic engineering, which randomly incorporates genetic material into the host genome, gene editing aims to make changes at specific target locations.Genome editing technology is a technique for target gene modification that allows the knockout and addition of specific fragments of DNA. This technique is widely used in biomedical research, clinics, and agriculture. A growing preference for personalized medicine, rare disease treatment research, rising R&D spending and growth in the pharmaceutical and biotech industries, rapid advances in sequencing and genome editing technologies, and increasing use of products derived from genetically modified organisms. These are some of the factors that are boosting the growth of the U.S. gene editing market.
Market Dynamics
Market Opportunities & Trends
Emergence of Novel Gene Editing Tools Use of Gene Editing in Personalized Medicine Increased Pharma/Biotech, Venture Capital & Government Funding for Gene Editing Projects High Number of Gene Editing-Based Investigational Drugs
Market Growth Enablers
Advances in Genome Editing Platforms Large Target Population With Rare Genetic Disorders Demand for Gene Editing in Drug Discovery & Development Diverse Applications of Gene Editing
Market Restraints
High Cost & Time Involved in Gene Editing Technical Challenges Related to Gene Editing Ethical & Safety Concerns Associated With Gene Editing
SEGMENTATIONS Segmentation by Products
Reagents & Consumables Equipment & Software Services
Segmentation by Technology
Segmentation by Application
Drug Discovery & Development (DDD) Animal Gene Editing Plant Gene Editing Others
Segmentation by End User
Pharma & Biotech Companies (PBC) Academic & Research Institutes (ARI) Animal & Plant Biotech Companies (APBC) CROs/CDMOs
Key Vendors
Agilent Technologies Creative Biogene Genscript Merck KGaA Thermo Fisher Scientific Takara Bio
Other Prominent Vendors
Arbor Biotechnologies Beam Therapeutics Bluebird Bio Cellectis Caribou Biosciences Charles River Laboratories CRISPR Therapeutics HERA Biolabs Integrated DNA Technologies Lonza New England Biolabs OriGene Technologies Synthego Tecan PerkinElmer Precision BioSciences Intellia Therapeutics Pairwise Sangamo Therapeutics Recombinetics Synbio Technologies
Key Topics Covered: 1 Research Methodology 2 Research Objectives 3 Research Process 4 Scope & Coverage 5 Report Assumptions & Caveats 6 Market at a Glance 7 Premium Insights 8 Introduction 9 Market Opportunities & Trends 10 Market Growth Enablers 11 Market Restraints 12 Market Landscape 13 Product 14 Technology 15 Application 16 End-User 17 Competitive Landscape 18 Key Company Profiles 19 Other Prominent Vendors 20 Report Summary 21 Quantitative Summary 22 Appendix Companies Mentioned
Agilent Technologies Creative Biogene Genscript Merck KGaA Thermo Fisher Scientific Takara Bio Arbor Biotechnologies Beam Therapeutics Bluebird Bio Cellectis Caribou Biosciences Charles River Laboratories CRISPR Therapeutics HERA Biolabs Integrated DNA Technologies Lonza New England Biolabs OriGene Technologies Synthego Tecan PerkinElmer Precision BioSciences Intellia Therapeutics Pairwise Sangamo Therapeutics Recombinetics Synbio Technologies
For more information about this report visit
Media Contact:
Research and MarketsLaura Wood, Senior Manager[email protected]
For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
Logo:
SOURCE Research and Markets
MENAFN25112022003732001241ID1105233504
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.